Shares of Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.93 and traded as low as $0.44. Evoke Pharma shares last traded at $0.55, with a volume of 19,055 shares trading hands.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on shares of Evoke Pharma in a research report on Thursday. They set a “sell” rating for the company.
View Our Latest Research Report on EVOK
Evoke Pharma Price Performance
Evoke Pharma (NASDAQ:EVOK – Get Free Report) last announced its earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share for the quarter. Evoke Pharma had a negative net margin of 150.43% and a negative return on equity of 517.99%. The firm had revenue of $1.68 million during the quarter.
Evoke Pharma Company Profile
Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.
See Also
- Five stocks we like better than Evoke Pharma
- Health Care Stocks Explained: Why You Might Want to Invest
- Comprehensive Analysis of PayPal Stock
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Stock Sentiment Analysis: How it Works
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Evoke Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke Pharma and related companies with MarketBeat.com's FREE daily email newsletter.